(Q38794619)

English

Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression

scientific article published on 12 February 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Tsui-Hwa Tseng

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Ming-Hsien Chien

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Wea-Lung Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Yu-Ching Wen

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jyh-Ming Chow

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chi-Kuan Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Tsang-Chih Kuo

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Wei-Jiunn Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

12 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Environmental Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

434-444

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Treatment and care of patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Dietary agents in cancer prevention: flavonoids and isoflavonoids.

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Dietary components impact histone modifications and cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Triple-negative breast cancer: a short review

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Epigenetics in cancer: targeting chromatin modifications

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Phytochemicals potently inhibit migration of metastatic breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Triple-negative breast cancer: an unmet medical need

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Targeting histone deacetylase in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Histone deacetylase inhibitors: multifunctional anticancer agents.

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Cell cycle control as a basis for cancer chemoprevention through dietary agents

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Molecular profiling of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Apigenin: a promising molecule for cancer prevention

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Three-dimensional cell growth confers radioresistance by chromatin density modification

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Natural products as zinc-dependent histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation

1 reference

https://api.crossref.org/works/10.1002%2FTOX.22247

21 January 2018

Identifiers

10.1002/TOX.22247

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38794619&oldid=1786974876"